Drug Trial Radar · NCT02582996
Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
Last checked: Nov 19, 2026Latest source record: Apr 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
336
Planned (sponsor's estimate)
Start
Apr 2020
Primary completion
Apr 2021
Study completion Jun 2021
Sponsor
- Lead sponsor
- Ache Laboratorios Farmaceuticos S.A.Industry
- Sponsor type
- Industry
- First posted
- Oct 21, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
National clinical trials, phase III, randomized, open, parallel, study of superiority, in which three hundred thirty-six (336) participants of both sexes, aged between 18 and 65 years will be randomly allocated to one of two treatment groups. The Group 01 will use Cefalium® and group 02 will use Tylenol®.
Conditions
- Migraine
Interventions
Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.Drug
The subject must manage 02 tablets of Cefalium right after a moderate to severe migraine.
AcetaminophenDrug
The subject must manage 02 tablets of Tylenol right after a moderate to severe migraine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain relief of Cefalium® compared to Tylenol®Time frame: 2 hours
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Centro de Desenvolvimento em Estudos Clínicos Brasil - CDEC Brasil
São Paulo, Brazil
Cepic - Centro Paulista de Investigação Clínica
São Paulo, Brazil
CPCLIN - Centro de Pesquisas Clinicas Ltda
São Paulo, Brazil
Universidade Federal de São Paulo - Núcleo de Gestão de Pesquisa/HU/FAP
São Paulo, Brazil
Centro de Pesquisa Clínica - CPEC / Associação Obras Sociais Irmã Dulce
Salvador, Estado de Bahia, Brazil
Centro de Pesquisa Clínica Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.